Paul N. NewtonAbdinasir A. AminChris BirdPhillip PassmoreGraham DukesGöran TomsonBright SimonsRoger BatePhilippe J. GuerinNicholas J. WhiteMahosot HospitalNuffield Department of Clinical MedicineUniversity of OxfordPopulation Services InternationalWellcome TrustCurtin UniversityUniversitetet i OsloKarolinska InstitutetIMANI Center for Policy and EducationAmerican Enterprise InstituteMahidol University2018-05-032018-05-032011-12-01PLoS Medicine. Vol.8, No.12 (2011)15491676154912772-s2.0-84855175196https://repository.li.mahidol.ac.th/handle/20.500.14594/12216Mahidol UniversityMedicineThe primacy of public health considerations in defining poor quality medicinesArticleSCOPUS10.1371/journal.pmed.1001139